New Insights in Intravesical Treatment for Intermediate- and High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma

被引：5
作者：
Babjuk, Marko [1 ]
机构：
[1] Charles Univ Prague, Fac Med 2&1, Dept Urol, FN Motol, Prague 15006 5, Czech Republic
来源：
EUROPEAN UROLOGY | 2010年 / 57卷 / 05期
关键词：
CANCER;
D O I：
10.1016/j.eururo.2010.01.004
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：774 / 776
页数：3
相关论文
共 8 条
[1]   EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].
Babjuk, Marko ;
Oosterlinck, Willem ;
Sylvester, Richard ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou-Redorta, Juan .
EUROPEAN UROLOGY, 2008, 54 (02) :303-314
[2]   Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer [J].
Hendricksen, Kees ;
Witjes, Wim P. J. ;
Idema, Jan G. ;
Kums, Jan J. M. ;
Trip, Oncko B. van Vierssen ;
de Bruin, Marcel J. F. M. ;
Vergunst, Henk ;
Caris, Christien T. M. ;
Janzing-Pastors, Maria H. D. ;
Witjes, J. Alfred .
EUROPEAN UROLOGY, 2008, 53 (05) :984-991
[3]   Bladder cancer subtypes defined by genomic alterations [J].
Knowles, Margaret A. .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 :116-130
[4]   An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer [J].
Malmstrom, Per-Uno ;
Sylvester, Richard J. ;
Crawford, David E. ;
Friedrich, Martin ;
Krege, Susanne ;
Rintala, Erkki ;
Solsona, Eduardo ;
Di Stasi, Savino M. ;
Witjes, J. Alfred .
EUROPEAN UROLOGY, 2009, 56 (02) :247-256
[5]   Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: The concept of lymph node density [J].
Stein, JP ;
Cai, J ;
Groshen, S ;
Skinner, DG .
JOURNAL OF UROLOGY, 2003, 170 (01) :35-41
[6]   Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder [J].
Sylvester, Richard J. ;
Brausi, Maurizio A. ;
Kirkels, Wim J. ;
Hoeltl, Wolfgang ;
Da Silva, Fernando Calais ;
Powell, Philip H. ;
Prescott, Stephen ;
Kirkali, Ziya ;
van de Beek, Cees ;
Gorlia, Thierry ;
de Reijke, Theo M. .
EUROPEAN UROLOGY, 2010, 57 (05) :766-773
[7]   Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials [J].
Sylvester, RJ ;
van der Meijden, APM ;
Oosterlinck, W ;
Witjes, JA ;
Bouffioux, C ;
Denis, L ;
Newling, DWW ;
Kurth, K .
EUROPEAN UROLOGY, 2006, 49 (03) :466-477
[8]   High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility [J].
Zieger, Karsten .
MOLECULAR ONCOLOGY, 2008, 1 (04) :384-394
1